RAC1 and cancer: Nevertheless, we previously showed that the semi-automatic method that we used as a substitute, produced reliable results when we analyzed the effect of inhibitors or siRNA against EGFR [14, 37], MMP3 [38] or the Rho GTPases Rac1 and Rho [39] in cancer cells.